Nov 20, 2009 By:Erik Greb
GlaxoSmithKline (GSK) has agreed to donate 50 million doses of its adjuvanted pandemic influenza A (H1N1) vaccine to the World Health Organization (WHO).
 |
Nov 19, 2009 By:Erik Greb
Last week, GlaxoSmithKline (GSK, London) agreed to donate 50 million doses of its adjuvanted pandemic influenza A (H1N1) vaccine to the World Health Organization (WHO).
 |
Nov 18, 2009 By:Erik Greb
Recent advances in microreactor technology are improving the application and scale at which the technology can be applied.
 |
Nov 12, 2009 By:Erik Greb
On Sunday, Nov. 8, 2009, the Pharmaceutical Research and Manufacturers of America (PhRMA) expressed its disappointment with the US House of Representatives's healthcare-reform bill.
 |
Nov 6, 2009 By:Erik Greb
In response to a request from the FDA, the US Pharmacopeial Convention (USP) has revised its standards for propylene glycol and sorbitol solution, excipients widely used in prescription and over-the-counter drugs.
 |
Nov 5, 2009 By:Erik Greb
In response to a request from the US Food and Drug Administration, the US Pharmacopeial Convention (USP) revised its standards for propylene glycol and sorbitol solution
 |
Oct 30, 2009 By:Erik Greb
The FDA is using prescription data from Wolters Kluwer Pharma Solutions to track the treatment of influenza A (H1N1) and other influenza viruses.
 |
Oct 29, 2009 By:Erik Greb
The US Food and Drug Administration is using prescription data from Wolters Kluwer Pharma Solutions to track the treatment of influenza A (H1N1) and other influenza viruses, according to a statement that the company released last week.
 |
Oct 21, 2009 By:Erik Greb
PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the October 2009 edition from Emerson and Minitab.
 |
|